EUVIMEDEUVIMED entdecken
Crossref

Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel

Feras Haskiah, Abid Khaskia

Journal of Clinical Lipidology · 2023

DOI: 10.1016/j.jacl.2023.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2023. Verfasst von Feras Haskiah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electr…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anticholesteremic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are significant health gaps between Arabs and Jews in Israel. However, there are limited data on the management and treatment of dyslipidemia among Israeli adults who experience premature acute coronary syndrome (ACS). This study aimed to assess the differences between Arabs and Jews with regard to lipid-lowering therapy administration and low-density lipoprotein cholesterol (LDL-C) levels goal attainment at 1 year post-ACS. METHODS: This study included patients aged ≤55 years who had been hospitalized for ACS at Meir Medical Center between 2018 and 2019. Outcomes included the rate of use of lipid-lowering medications, LDL-C levels 1 year post-admission, and major adverse cardiovascular and cerebrovascular events (MACCE) during 30 months of follow-up. RESULTS: The study population comprised 687 young adults with a median age of 48.5 years. 81.9% of the Arab patients and 79.8% of the Jewish patients were discharged on high intensity statins. At 1 year of follow-up, the proportions of Arab patients who had LDL-C levels

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeHydroxymethylglutaryl-CoA Reductase InhibitorsAnticholesteremic AgentsHumansMiddle AgedIsraelCholesterol, LDLGoals

Stichwörter der Autor:innen

Acute coronary syndromeEzetimibeLipid-lowering therapyLow-density lipoprotein cholesterolPCSK9i

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsAnticholesteremic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: Feras.haskiah@mail.huji.ac.il.
  • Department of Cardiology, Meir Medical Center, Kfar Saba, Israel.

Zitieren

APA

Haskiah, F., & Khaskia, A. (2023). Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2023.04.002

Vancouver

Haskiah F, Khaskia A. Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel. Journal of Clinical Lipidology. 2023. doi:10.1016/j.jacl.2023.04.002

BibTeX
@article{Haskiah2023,
  author = {Haskiah, Feras and Khaskia, Abid},
  title = {Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel},
  journal = {Journal of Clinical Lipidology},
  year = {2023},
  doi = {10.1016/j.jacl.2023.04.002}
}
Kostenlos starten →